OBJECTIVE: Schizophrenia is a devastating and common psychiatric disorder which is associated with a high degree of medical morbidity and reduced life span in addition to psychosis. In this article, these problems will be discussed in the context of schizophrenia and aging. METHOD: The recent literature was reviewed using Pubmed, Medline, and Google scholar with the search terms "schizophrenia, aging, medical problems." RESULTS: Schizophrenia is associated with significant medical morbidity and mortality. Diabètes and cardiovascular disease, along with smoking and obesity, are over-represented and contribute to reduced quality of life and life span. Schizophrenics often receive poor medical care. CONCLUSIONS: The impacts of schizophrenia on physical health and successful aging have been underestimated. Psychiatrists and primary care physicians need to address the overlapping medical and psychiatric aspects of the disorder while the medical care system for these patients requires a much higher degree of coordination than is currently available.
OBJECTIVE:Schizophrenia is a devastating and common psychiatric disorder which is associated with a high degree of medical morbidity and reduced life span in addition to psychosis. In this article, these problems will be discussed in the context of schizophrenia and aging. METHOD: The recent literature was reviewed using Pubmed, Medline, and Google scholar with the search terms "schizophrenia, aging, medical problems." RESULTS:Schizophrenia is associated with significant medical morbidity and mortality. Diabètes and cardiovascular disease, along with smoking and obesity, are over-represented and contribute to reduced quality of life and life span. Schizophrenics often receive poor medical care. CONCLUSIONS: The impacts of schizophrenia on physical health and successful aging have been underestimated. Psychiatrists and primary care physicians need to address the overlapping medical and psychiatric aspects of the disorder while the medical care system for these patients requires a much higher degree of coordination than is currently available.
Authors: Arthur L Brody; Todd Zorick; Robert Hubert; Gerhard S Hellemann; Shabnam Balali; Sarah S Kawasaki; Lizette Y Garcia; Ryutaro Enoki; Paul Abraham; Paulina Young; Charles McCreary Journal: Nicotine Tob Res Date: 2016-08-03 Impact factor: 4.244
Authors: Marco Innamorati; Stefano Baratta; Cristina Di Vittorio; David Lester; Paolo Girardi; Maurizio Pompili; Mario Amore Journal: Schizophr Res Treatment Date: 2013-01-21
Authors: Ah Rang Cho; Sang Min Lee; Won Sub Kang; Su Kang Kim; Joo-Ho Chung Journal: Clin Psychopharmacol Neurosci Date: 2012-08-31 Impact factor: 2.582
Authors: Jack Y Tsan; Eileen M Stock; Jazmin M Gonzalez; David S Greenawalt; John E Zeber; Emran Rouf; Laurel A Copeland Journal: BMC Med Date: 2012-11-26 Impact factor: 8.775
Authors: Thomas R Einarson; Maria Geitona; Alexandros Chaidemenos; Vasiliki Karpouza; Theodoros Mougiakos; Periklis Paterakis; Dimitrios Ploumpidis; Dionyssios Potamitis-Komis; Roman Zilbershtein; Colin Vicente; Charles Piwko; Panagiotis Kakkavas; Konstantina Paparouni; Rasmus C D Jensen; Michiel E H Hemels Journal: Ann Gen Psychiatry Date: 2012-07-02 Impact factor: 3.455
Authors: Diane H Fredrikson; Heidi N Boyda; Lurdes Tse; Zachary Whitney; Mark A Pattison; Fred J Ott; Laura Hansen; Alasdair M Barr Journal: Front Psychiatry Date: 2014-09-05 Impact factor: 4.157